Investigating the pathogenesis of KIF1A Associated Neurological Disorder (KAND) and identifying therapeutic targets using C.elegans nerve cells.
(Cell Bio 2024 2024)
In silico isolation, In vitro analysis and in vivo validation of suppressors for KIF1A associated neurological disorder
(Cell Bio 2024 2024)
Investigating the pathogenesis of KIF1A Associated Neurological Disorder (KAND) and identifying therapeutic targets using C.elegans nerve cells
(EMBO | The Company of Biologists Workshop “Axonal Degeneration and Regeneration” 2024)